198 related articles for article (PubMed ID: 31531761)
1. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection.
Zhang X; Bai Y; Xu L; Zhang B; Feng S; Xu L; Zhang H; Xu L; Yang P; Niu T; Zheng S; Liu J
Hepatol Int; 2019 Nov; 13(6):715-725. PubMed ID: 31531761
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
5. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
6. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
[TBL] [Abstract][Full Text] [Related]
9. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.
Hao K; Luk JM; Lee NP; Mao M; Zhang C; Ferguson MD; Lamb J; Dai H; Ng IO; Sham PC; Poon RT
BMC Cancer; 2009 Nov; 9():389. PubMed ID: 19886989
[TBL] [Abstract][Full Text] [Related]
10. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Minagawa M; Makuuchi M; Takayama T; Kokudo N
Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
12. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
[TBL] [Abstract][Full Text] [Related]
15. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
16. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
17. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
18. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.
Nanashima A; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Tsuji T; Hidaka S; Sawai T; Yasutake T; Nakagoe T
Eur J Surg Oncol; 2003 Nov; 29(9):735-42. PubMed ID: 14602492
[TBL] [Abstract][Full Text] [Related]
19. Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
Kim HS; Yi NJ; Kim JM; Hong SK; Kwon CHD; Joh JW; Lee KW; Suh KS
ANZ J Surg; 2019 Mar; 89(3):216-222. PubMed ID: 30384395
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
